<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Triana S</submitter><funding>Deutsche Forschungsgemeinschaft (DFG)</funding><funding>Bundesministerium für Bildung und Forschung</funding><funding>Deutsche Forschungsgemeinschaft</funding><funding>European Research Council</funding><funding>Bundesministerium für Bildung und Forschung (BMBF)</funding><funding>DAAD</funding><pagination>e10232</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8077299</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>17(4)</volume><pubmed_abstract>Exacerbated pro-inflammatory immune response contributes to COVID-19 pathology. However, despite the mounting evidence about SARS-CoV-2 infecting the human gut, little is known about the antiviral programs triggered in this organ. To address this gap, we performed single-cell transcriptomics of SARS-CoV-2-infected intestinal organoids. We identified a subpopulation of enterocytes as the prime target of SARS-CoV-2 and, interestingly, found the lack of positive correlation between susceptibility to infection and the expression of ACE2. Infected cells activated strong pro-inflammatory programs and produced interferon, while expression of interferon-stimulated genes was limited to bystander cells due to SARS-CoV-2 suppressing the autocrine action of interferon. These findings reveal that SARS-CoV-2 curtails the immune response and highlights the gut as a pro-inflammatory reservoir that should be considered to fully understand SARS-CoV-2 pathogenesis.</pubmed_abstract><journal>Molecular systems biology</journal><pubmed_title>Single-cell analyses reveal SARS-CoV-2 interference with intrinsic immune response in the human gut.</pubmed_title><pmcid>PMC8077299</pmcid><funding_grant_id>416072091</funding_grant_id><funding_grant_id>272983813</funding_grant_id><funding_grant_id>01KI20198A</funding_grant_id><funding_grant_id>240245660</funding_grant_id><funding_grant_id>773089</funding_grant_id><funding_grant_id>415089553</funding_grant_id><funding_grant_id>278001972</funding_grant_id><funding_grant_id>01KI20239B</funding_grant_id><funding_grant_id>57440921</funding_grant_id><pubmed_authors>Boulant S</pubmed_authors><pubmed_authors>Metz-Zumaran C</pubmed_authors><pubmed_authors>Herrmann C</pubmed_authors><pubmed_authors>Sharma AK</pubmed_authors><pubmed_authors>Shahraz M</pubmed_authors><pubmed_authors>Schraivogel D</pubmed_authors><pubmed_authors>Gschwind AR</pubmed_authors><pubmed_authors>Alexandrov T</pubmed_authors><pubmed_authors>Ramirez C</pubmed_authors><pubmed_authors>Steinmetz LM</pubmed_authors><pubmed_authors>Stanifer ML</pubmed_authors><pubmed_authors>Triana S</pubmed_authors><pubmed_authors>Doldan P</pubmed_authors><pubmed_authors>Kee C</pubmed_authors></additional><is_claimable>false</is_claimable><name>Single-cell analyses reveal SARS-CoV-2 interference with intrinsic immune response in the human gut.</name><description>Exacerbated pro-inflammatory immune response contributes to COVID-19 pathology. However, despite the mounting evidence about SARS-CoV-2 infecting the human gut, little is known about the antiviral programs triggered in this organ. To address this gap, we performed single-cell transcriptomics of SARS-CoV-2-infected intestinal organoids. We identified a subpopulation of enterocytes as the prime target of SARS-CoV-2 and, interestingly, found the lack of positive correlation between susceptibility to infection and the expression of ACE2. Infected cells activated strong pro-inflammatory programs and produced interferon, while expression of interferon-stimulated genes was limited to bystander cells due to SARS-CoV-2 suppressing the autocrine action of interferon. These findings reveal that SARS-CoV-2 curtails the immune response and highlights the gut as a pro-inflammatory reservoir that should be considered to fully understand SARS-CoV-2 pathogenesis.</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Apr</publication><modification>2026-05-08T21:28:40.424Z</modification><creation>2022-02-10T14:47:39.862Z</creation></dates><accession>S-EPMC8077299</accession><cross_references><pubmed>33904651</pubmed><doi>10.15252/msb.202110232</doi></cross_references></HashMap>